Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DICERNA PHARMACEUTICALS, INC.

(DRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DICERNA PHARMACEUTICALS, INC.
10/20DICERNA PHARMACEUTICALS : Announces Results for PHYOX4, Single-Dose Study of Nedosiran in ..
AQ
10/19DICERNA PHARMACEUTICALS : Says Hyperoxaluria Treatment Met Safety Endpoint in Trial But Mi..
MT
10/19DICERNA PHARMACEUTICALS : Announces Results for PHYOX™4, Single-Dose Study of Nedosi..
BU
10/19Dicerna Announces Results for PHYOX™4, Single-Dose Study of Nedosiran in Primary Hypero..
CI
10/15DICERNA PHARMACEUTICALS : Announces Data to Be Presented at American Society of Nephrology..
BU
10/14DICERNA PHARMACEUTICALS : to Present Phase 1 Data for Two Drug Candidates at Liver Disease..
MT
10/14DICERNA PHARMACEUTICALS : Announces Poster Presentations at American Association for the S..
BU
10/14Dicerna Pharmaceuticals, Inc. Announces Poster Presentations at American Association fo..
CI
10/12DICERNA PHARMACEUTICALS : Corporate Overview
PU
10/01DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
09/29DICERNA PHARMACEUTICALS : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
AQ
09/28DICERNA PHARMACEUTICALS : Begins Early-Stage Trial of Potential Treatment for Alcoholic Us..
MT
09/28DICERNA PHARMACEUTICALS : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
BU
09/28Dicerna Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of DCR-AUD
CI
09/22DICERNA PHARMACEUTICALS : Names Rob Ciappenelli Chief Strategy Officer
MT
09/22DICERNA PHARMACEUTICALS : Announces New Executive Leadership Appointments
BU
09/22Dicerna Pharmaceuticals, Inc. Announces Executive Appointments
CI
09/21INSIDER SELL : Dicerna Pharmaceuticals
MT
09/07DICERNA PHARMACEUTICALS : Corporate Overview
PU
09/02DICERNA PHARMACEUTICALS : to Participate in 16th Annual Citi Biopharma Conference
BU
08/12DICERNA PHARMACEUTICALS : Corporate Overview
PU
08/12NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
08/11DICERNA PHARMACEUTICALS : B. Riley Lowers Dicerna Pharmaceuticals' PT to $35 from $49 on H..
MT
08/11DICERNA PHARMACEUTICALS : Goldman Sachs Cuts Dicerna Pharmaceuticals to Neutral From Buy, ..
MT
08/10INSIDER TRENDS : Insider Buying Continued with Purchase of Dicerna Pharmaceuticals Stock
MT
08/10DICERNA PHARMACEUTICALS : Chardan Capital Adjusts Price Target on Dicerna Pharmaceuticals ..
MT
08/10DICERNA PHARMACEUTICALS : HC Wainwright Adjusts Price Target on Dicerna Pharmaceuticals to..
MT
08/09UPDATE : Dicerna Pharma Logs Wider Q2 Loss, Revenue Up Slightly; Shares Fall
MT
08/09DICERNA PHARMACEUTICALS : Logs Wider Q2 Loss, Revenue Up Slightly
MT
08/09DICERNA PHARMACEUTICALS : Q2 Earnings Snapshot
AQ
08/09Dicerna Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended Jun..
CI
08/09DICERNA PHARMACEUTICALS : Citigroup Downgrades Dicerna Pharmaceuticals to Neutral From Buy..
MT
08/09DICERNA PHARMACEUTICALS : Earnings Flash (DRNA) DICERNA PHARMACEUTICALS Reports Q2 Revenue..
MT
08/09DICERNA PHARMACEUTICALS : Announces Second Quarter 2021 Financial Results and Provides a B..
BU
08/06Top Midday Decliners
MT
08/06DICERNA PHARMACEUTICALS : SVB Leerink Adjusts Price Target on Dicerna Pharmaceuticals to $..
MT
08/06DICERNA PHARMACEUTICALS : Goldman Sachs Adjusts Price Target on Dicerna Pharmaceuticals to..
MT
08/06Wall Street Sees Narrowly Mixed Open, Strong Jobs Data in Focus
MT
08/06Top Premarket Decliners
MT
08/06DICERNA PHARMACEUTICALS : RBC Cuts Price Target on Dicerna Pharmaceuticals to $30 From $35..
MT
08/06DICERNA PHARMACEUTICALS : Cowen Downgrades Dicerna Pharmaceuticals to Market Perform From ..
MT
08/06DICERNA PHARMACEUTICALS : Truist Securities Downgrades Dicerna Pharmaceuticals to Hold Fro..
MT
08/06DICERNA PHARMACEUTICALS : Declines Pre-Bell Friday After Primary Hyperoxaluria Subtype 2 P..
MT
08/05DICERNA PHARMACEUTICALS : Reports Positive Top-Line Results From PHYOX™2 Pivotal Cli..
BU
08/05Dicerna Pharmaceuticals, Inc. Reports Positive Top-Line Results From PHYOX™2 Pivotal Cl..
CI
08/02DICERNA PHARMACEUTICALS : to Report Second Quarter 2021 Financial Results on Aug. 9, 2021
BU
07/30DICERNA PHARMACEUTICALS : Announces FDA Clearance of Investigational New Drug Application ..
AQ
07/29DICERNA PHARMACEUTICALS' : New Drug Application Targeting Alcohol Use Disorder Gets FDA Cl..
MT
07/29DICERNA PHARMACEUTICALS : Announces FDA Clearance of Investigational New Drug (IND) Applic..
BU
07/29Dicerna Pharmaceuticals, Inc. Announces FDA Clearance of Investigational New Drug Appli..
CI
07/29Dicerna Announces FDA Clearance of Investigational New Drug Application for DCR-AUD for..
CI
07/23DICERNA PHARMACEUTICALS : Corporate Overview
PU
07/21SECTOR UPDATE : Health Care Stocks Mixed Ahead of Wednesday Close
MT
07/21SECTOR UPDATE : Health Care Stocks Mixed, Nearly Flat Wednesday
MT
07/21DICERNA PHARMACEUTICALS : Reports Positive Interim Data From Phase 1 Study of Belcesiran i..
MT
07/21DICERNA PHARMACEUTICALS : Announces Interim Results From Phase 1 Trial of Belcesiran for T..
BU
07/21Dicerna Pharmaceuticals, Inc Announces Interim Results From Phase 1 Trial of Belcesiran..
CI
07/08DICERNA PHARMACEUTICALS : Corporate Overview
PU
07/02DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
07/01DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
06/25DICERNA PHARMACEUTICALS : B. Riley Raises Dicerna Pharmaceuticals' PT to $49 from $40 to R..
MT
06/23DICERNA PHARMACEUTICALS : HC Wainwright Adjusts Dicerna Pharmaceuticals' Price Target to $..
MT
06/22DICERNA PHARMACEUTICALS : Starts Patient Dosing in Phase 2 Trial for Rare Liver Disease Dr..
MT
06/22DICERNA PHARMACEUTICALS : Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of B..
BU
06/22Dicerna Pharmaceuticals, Inc. Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Tri..
CI
06/17INSIDER TRENDS : Dicerna Pharmaceuticals Insider Converts/Exercises Derivative Security, S..
MT
06/17DICERNA PHARMACEUTICALS : Announces Dosing Completion in Nedosiran PHYOX4 Clinical Trial f..
AQ
06/16DICERNA PHARMACEUTICALS : Completes Dosing in Study of Nedosiran to Treat Primary Hyperoxa..
MT
06/16DICERNA PHARMACEUTICALS : Announces Dosing Completion in Nedosiran PHYOX™4 Clinical ..
BU
06/16Dicerna Pharmaceuticals, Inc. Announces Dosing Completion in Nedosiran Phyox4 Clinical ..
CI
06/11Vertex Won't Move VX-864 into Late-Stage Testing After Disappointing Study Results
MT
06/03DICERNA PHARMACEUTICALS : to Participate in 42nd Annual Goldman Sachs Global Healthcare Co..
BU
06/01DICERNA PHARMACEUTICALS : Corporate Overview
PU
05/28DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational New Drug (IN..
AQ
05/27DICERNA PHARMACEUTICALS : Says Partner Eli Lilly's Investigational New Drug Application fo..
MT
1  2  3  4  5  6  7  8Next
Upcoming event on DICERNA PHARMACEUTICALS, INC.